EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION ANALYSES IN TUMOR AND PLASMA SAMPLES FROM A PHASE IV, SINGLE-ARM STUDY OF FIRST-LINE GEFITINIB IN CAUCASIAN PATIENTS WITH EGFR MUTATION-POSITIVE, ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)

被引：0
|
作者：
Douillard, Jean-Yves [1 ]
Ostoros, Gyula [2 ]
Cobo, Manuel [3 ]
Ciuleanu, Tudor [4 ]
Mccormack, Rose [7 ]
Webster, Alan [5 ]
Milenkova, Tsveta [6 ]
机构：
[1] Ico R Gauducheau, St Herblain, France
[2] Koranyi Natl Inst Tb & Pulmonol, Budapest, Hungary
[3] Hru Carlos Haya, Malaga, Spain
[4] Prof Dr Ion Chiricuta Inst Oncol, Cluj Napoca, Romania
[5] Astrazeneca, Biometr & Informat Sci, Cambridge, England
[6] Astrazeneca, Res & Dev, Cambridge, England
[7] Astrazeneca, Personalised Healthcare, Luton, Beds, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
EGFR mutation; gefitinib; NSCLC; Caucasian; circulating-free DNA;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-020
引用
收藏
页码：S1194 / S1195
页数：2
相关论文
共 50 条
  • [1] PHASE IV, SINGLE-ARM STUDY OF FIRST-LINE GEFITINIB IN CAUCASIAN PATIENTS WITH EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) MUTATION-POSITIVE, ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): POST-HOC EXPLORATORY ANALYSES OF EGFR MUTATIONS IN PLASMA-DERIVED CFDNA SAMPLES
    Douillard, Jean-Yves
    Ostoros, Gyula
    Cobo, Manuel
    Ciuleanu, Tudor
    Mccormack, Rose
    Webster, Alan
    Milenkova, Tsveta
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S899 - S900
  • [2] First-line gefitinib in Caucasian patients (pts) with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC): Results from a multinational, prospective,,open-label, single-arm Phase IV study
    Ostoros, G.
    Cobo, M.
    Ciuleanu, T.
    McCormack, R.
    Webster, A.
    Milenkova, T.
    Douillard, J. Y.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S820 - S820
  • [3] First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
    J-Y Douillard
    G Ostoros
    M Cobo
    T Ciuleanu
    R McCormack
    A Webster
    T Milenkova
    British Journal of Cancer, 2014, 110 : 55 - 62
  • [4] First-line gefitinib in Caucasian EGFR mutation-positive NSCLC patients: a phase-IV, open-label, single-arm study
    Douillard, J-Y
    Ostoros, G.
    Cobo, M.
    Ciuleanu, T.
    McCormack, R.
    Webster, A.
    Milenkova, T.
    BRITISH JOURNAL OF CANCER, 2014, 110 (01) : 55 - 62
  • [5] FIRST-LINE GEFITINIB IN EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION-POSITIVE (EGFR plus ) NON-SMALL CELL LUNG CANCER (NSCLC) IN AN ISRAELI COHORT
    Ben-Arieh, S.
    Urban, D.
    Maimon, N.
    Leibowitz-Amit, R.
    Keizman, D.
    Biran, H.
    Mishaeli, M.
    Onn, A.
    Gottfried, M.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [6] EGFR TKI as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer
    Nan, Xueli
    Xie, Chao
    Yu, Xueyan
    Liu, Jie
    ONCOTARGET, 2017, 8 (43) : 75712 - 75726
  • [7] First-line treatment of EGFR mutation-positive non-small cell lung cancer (NSCLC) by gefitinib
    Moiseyenko, V.
    Procenko, S. A.
    Levchenko, E. V.
    Barchuk, A. S.
    Matsko, D. E.
    Moiseyenko, F. V.
    Ivantsov, A. O.
    Iyevleva, A. G.
    Mitiushkina, N. V.
    Imyanitov, E. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Osimertinib As First-Line Treatment of EGFR Mutation-Positive Advanced Non-Small-Cell Lung Cancer
    Ramalingam, Suresh S.
    Yang, James C-H
    Lee, Chee Khoon
    Kurata, Takayasu
    Kim, Dong-Wan
    John, Thomas
    Nogami, Naoyuki
    Ohe, Yuichiro
    Mann, Helen
    Rukazenkov, Yuri
    Ghiorghiu, Serban
    Stetson, Daniel
    Markovets, Aleksandra
    Barrett, J. Carl
    Thress, Kenneth S.
    Janne, Pasi A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (09) : 841 - +
  • [9] Continuation of gefitinib beyond progression in patients with EGFR mutation-positive non-small-cell lung cancer: A phase II single-arm trial
    Lim, Sung Won
    Park, Sehhoon
    Kim, Youjin
    Cho, Jang Ho
    Park, Song Ee
    Lee, Hansang
    Kim, Hee Kyung
    Kim, Sung Min
    Sun, Jong Mu
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    LUNG CANCER, 2018, 124 : 293 - 297
  • [10] Data reported for gefitinib use in Caucasian EGFR mutation-positive non-small-cell lung cancer patients
    Lake, Francesca
    FUTURE ONCOLOGY, 2013, 9 (07) : 930 - 930
12345